State News

Displaying results 1-10 (of 77)
 |<  < 1 2 3 4 5 6 7 8  >  >| 

FSR President Testifies on PBMs and the Rebate System

Dr. Robert Levin, President of the Florida Society of Rheumatology recently testified to the House Health Innovation Subcommittee on the role that Pharmacy Benefit Managers have played in inflating the cost of prescription drugs.

READ MORE

CSRO & FSR Discuss Utilization Management in Tallahassee

On Tuesday, December 5th, CSRO hosted a reception for Florida legislators in partnership with the Florida Society of Rheumatology (FSR). An array of stakeholders including patients and physicians met and spoke with legislators that are deeply invested in CSRO and FSR’s shared priorities.

READ MORE

CSRO Delivers Testimony on Utah Step Therapy

On September 20, 2017, Dr. Joshua Stolow traveled to Utah to testify on the necessity of patient protection legislation addressing step therapy protocols.

READ MORE

Legal Challenges to Nevada Drug Transparency Law Forecast Future Hurdles for Lawmakers

Nevada Governor Brian Sandoval signed a landmark drug transparency law in June that focuses on diabetes drug manufacturers and their intermediaries more broadly.

READ MORE

Step-Therapy Legislation Nears Effective Enrollment Date in Texas

Patients and physicians in Texas won a major victory against the step-therapy protocols instituted by insurance companies this spring with the passage of Senate Bill 680.

READ MORE

FDA Creates Pathway for Interchangeable Biologics

The FDA has released its highly anticipated but long delayed interchangeability guidelines, and the market seems primed for new developments.

READ MORE

States move to enforce FDA’s Biosimilar Interchangeability Guidelines from the Ground Up

The Food and Drug Administration’s guidelines for biosimilar interchangeability, released in January 2017, have come under renewed focus with concerns about patients being switched onto biosimilars by insurers without consultation with their physicians.

READ MORE

California Takes Aim at Pharmacy Benefit Managers With Assembly Bill 315

California’s Assembly Bill 315, which takes aim at Pharmacy Benefit Managers (PBMs), recently cleared the Assembly floor, and is now headed to the Senate for consideration.

READ MORE

State Rheumatology Organizations Join Alliance for Transparent & Affordable Prescriptions

The Florida Society of Rheumatology, New York State Rheumatology Society, and California Rheumatology Alliance today became the newest members of the Alliance for Transparent & Affordable Prescriptions (ATAP), a new coalition of provider and patient groups concerned about the role of pharmacy benefit managers (PBMs) in driving up drug costs.

READ MORE

The Atlantic Hosts Biosimilars Policy Roundtable.

The Atlantic recently concluded its policy roundtable on biosimilars June 7th, with the third and final installment titled: “The Next Drugs: An Atlantic Policy Update on Biosimilars.”

READ MORE

Displaying results 1-10 (of 77)
 |<  < 1 2 3 4 5 6 7 8  >  >|